Literature DB >> 25083250

Community pharmacists' knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia.

Tahir M Khan1.   

Abstract

OBJECTIVE: The present study aims to analyze community pharmacists' current knowledge and perceived barriers to adverse drug reaction (ADR) reporting systems in the Eastern region, Alahsa, Saudi Arabia.
METHOD: A cross-sectional study was planned from 1 June 2012 to 15 July 2012 among the community pharmacies in the Eastern region, Alahsa. A total of 70 community pharmacists were approached using a cluster sampling method. A self-administered, 28-item questionnaire was used to attain the objectives of the study. Data analysis was done using Statistical Package for Social Science version 13. Relative index ranking was used to identify the top five barriers to the ADR reporting process.
RESULTS: Response to the survey was 71.43%. In terms of knowledge about ADRs, very few (four, 8.0%) pharmacists were unable to differentiate between the right and wrong definition of ADRs. About 42 (84.0%) pharmacists mentioned that patients often report adverse events. However, 45 (90.0%) were not aware of the ADR reporting system in Saudi Arabia. A deficient professional environment was the main barrier to the ADR reporting process. In addition, unavailability of the reporting forms and poor understanding of the reporting process were common barriers to the reporting process.
CONCLUSION: Most of the community pharmacists were unaware of the ADR reporting system in Saudi Arabia. Logistic issues were the main barriers to the ADR reporting process.

Entities:  

Keywords:  Saudi Arabia; adverse drug reaction; barriers; community pharmacists; knowledge

Year:  2013        PMID: 25083250      PMCID: PMC4110832          DOI: 10.1177/2042098612474292

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN: 2042-0986


  23 in total

1.  Underreporting of adverse drug reactions: attitudes of Irish doctors.

Authors:  D Williams; J Feely
Journal:  Ir J Med Sci       Date:  1999 Oct-Dec       Impact factor: 1.568

2.  Reporting of adverse drug reactions by nurses.

Authors:  Sally Morrison-Griffiths; Thomas J Walley; B Kevin Park; Alasdair M Breckenridge; Munir Pirmohamed
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

3.  Pharmacists' role in reporting adverse drug reactions in an international perspective.

Authors:  Kees van Grootheest; Sten Olsson; Mary Couper; Lolkje de Jong-van den Berg
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-07       Impact factor: 2.890

Review 4.  Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review.

Authors:  Shobha Phansalkar; Jennifer M Hoffman; Jonathan R Nebeker; John F Hurdle
Journal:  Am J Health Syst Pharm       Date:  2007-04-15       Impact factor: 2.637

5.  Development of a computerized adverse drug event monitor.

Authors:  R S Evans; S L Pestotnik; D C Classen; S B Bass; R L Menlove; R M Gardner; J P Burke
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1991

Review 6.  Adverse drug reactions.

Authors:  M Pirmohamed; A M Breckenridge; N R Kitteringham; B K Park
Journal:  BMJ       Date:  1998-04-25

7.  [Direct reporting of side effects by the patient: favourable experience in the first year].

Authors:  A C van Grootheest; J L M Passier; E P van Puijenbroek
Journal:  Ned Tijdschr Geneeskd       Date:  2005-03-05

8.  Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong.

Authors:  K K Lee; T Y Chan; K Raymond; J A Critchley
Journal:  Ann Pharmacother       Date:  1994-12       Impact factor: 3.154

9.  Computerized surveillance of adverse drug events in hospital patients.

Authors:  D C Classen; S L Pestotnik; R S Evans; J P Burke
Journal:  JAMA       Date:  1991-11-27       Impact factor: 56.272

Review 10.  Data quality management in pharmacovigilance.

Authors:  Marie Lindquist
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

View more
  21 in total

1.  Reporting of Adverse Drug Reactions in Primary Care Settings in Kuwait: A Comparative Study of Physicians and Pharmacists.

Authors:  Jacinthe Lemay; Fatemah M Alsaleh; Lulwa Al-Buresli; Mohammed Al-Mutairi; Eman A Abahussain; Tania Bayoud
Journal:  Med Princ Pract       Date:  2018-01-29       Impact factor: 1.927

2.  The consequences of nonprescription medication sales in Saudi Arabia's community pharmacies: regulations without implementation.

Authors:  Tahir M Khan
Journal:  Ther Adv Drug Saf       Date:  2014-08

3.  Barriers to the success of an electronic pharmacovigilance reporting system in Kenya: an evaluation three years post implementation.

Authors:  Oscar O Agoro; Sarah W Kibira; Jenny V Freeman; Hamish S F Fraser
Journal:  J Am Med Inform Assoc       Date:  2018-06-01       Impact factor: 4.497

4.  Pharmacovigilance in developing countries (part I): importance and challenges.

Authors:  Shaimaa Elshafie; Iman Zaghloul; Anne Marie Roberti
Journal:  Int J Clin Pharm       Date:  2018-08

5.  A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England.

Authors:  Kinan Mokbel; Rob Daniels; Michael N Weedon; Leigh Jackson
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

6.  Public attitude and justification to purchase antibiotics in the Eastern region Al Ahsa of Saudi Arabia.

Authors:  Promise M Emeka; Mokhtar Al-Omar; Tahir M Khan
Journal:  Saudi Pharm J       Date:  2014-03-20       Impact factor: 4.330

7.  Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh.

Authors:  Mohammad Nurul Amin; Tahir Mehmood Khan; Syed Masudur Rahman Dewan; Mohammad Safiqul Islam; Mizanur Rahman Moghal; Long Chiau Ming
Journal:  BMJ Open       Date:  2016-08-03       Impact factor: 2.692

8.  How to improve suspected ADR reporting among pharmacists in the GCC?

Authors:  Kerry Wilbur
Journal:  Saudi Pharm J       Date:  2015-05-09       Impact factor: 4.330

9.  Pharmacovigilance Perception and Knowledge Among Pharmacists and Interns in Saudi Arabia.

Authors:  Dhfer Alshayban; Mansour Adam Mahmoud; Md Ashraful Islam; Shouq Alshammari; Duaa Alsulaiman
Journal:  Risk Manag Healthc Policy       Date:  2020-01-24

Review 10.  Drug safety: The concept, inception and its importance in patients' health.

Authors:  Thamir M Alshammari
Journal:  Saudi Pharm J       Date:  2014-05-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.